Enlivex Therapeutics Ltd. (TLV:ENLV)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
366.00
-12.70 (-3.35%)
Apr 1, 2025, 4:39 PM IDT

Enlivex Therapeutics Statistics

Total Valuation

TLV:ENLV has a market cap or net worth of ILS 79.44 million. The enterprise value is -8.96 million.

Market Cap 79.44M
Enterprise Value -8.96M

Important Dates

The last earnings date was Friday, March 28, 2025.

Earnings Date Mar 28, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +10.44%
Shares Change (QoQ) +5.70%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 16.06M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio 0.92
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 0.16
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 0.19

Financial Position

The company has a current ratio of 6.84

Current Ratio 6.84
Quick Ratio 6.18
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -55.95% and return on invested capital (ROIC) is -35.50%.

Return on Equity (ROE) -55.95%
Return on Assets (ROA) -30.10%
Return on Invested Capital (ROIC) -35.50%
Return on Capital Employed (ROCE) -65.04%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -72.69% in the last 52 weeks. The beta is 1.11, so TLV:ENLV's price volatility has been higher than the market average.

Beta (5Y) 1.11
52-Week Price Change -72.69%
50-Day Moving Average 393.35
200-Day Moving Average 457.84
Relative Strength Index (RSI) 42.72
Average Volume (20 Days) 32,393

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -56.59M
Pretax Income -54.69M
Net Income -54.69M
EBITDA -54.60M
EBIT -56.59M
Earnings Per Share (EPS) -2.67
Full Income Statement

Balance Sheet

The company has 85.58 million in cash and n/a in debt, giving a net cash position of 85.58 million.

Cash & Cash Equivalents 85.58M
Total Debt n/a
Net Cash 85.58M
Net Cash Per Share n/a
Equity (Book Value) 85.92M
Book Value Per Share 3.63
Working Capital 80.84M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -47.38 million and capital expenditures -375,157, giving a free cash flow of -47.75 million.

Operating Cash Flow -47.38M
Capital Expenditures -375,157
Free Cash Flow -47.75M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TLV:ENLV does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -10.44%
Shareholder Yield -10.44%
Earnings Yield -68.84%
FCF Yield -60.12%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a